Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Follow-Up Questions
Uni-Bio Science Group Ltd 的 CEO 是誰？
Mr. Zhi Gang Zhao 是 Uni-Bio Science Group Ltd 的 Chief Executive Officer，自 2014 加入公司。
UNBSF 股票的價格表現如何？
UNBSF 的當前價格為 $0，在上個交易日 decreased 了 0%。
Uni-Bio Science Group Ltd 的主要業務主題或行業是什麼？
Uni-Bio Science Group Ltd 屬於 Biotechnology 行業，該板塊是 Health Care
